PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
BURLINGTON, Mass.--(BUSINESS WIRE)--Apr 23, 2024--
Source: eagletribune.com
Albert Qin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Albert Qin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Albert Qin Today - Breaking & Trending Today
NCCN Lists Ropeginterferon Alfa-2B As Preferred First-Line Cytoreductive Therapy for PV
The National Comprehensive Cancer Network recommends ropeginterferon alfa-2b as first-line cytoreductive therapy for polycythemia vera.
Source: onclive.com
New Data on Ropeginterferon Alfa-2b to Be Featured at EHA2022
Presentations to illustrate long-term results from the PROUD/CONTINUATION studies as well as new insights on ropeginterferon alfa-2b in polycythemia vera (PV) patients in JapanTAIPEI--(BUSINESS WIRE)--PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep experti...
Source: pharmiweb.com
PharmaEssentia Corporation: New Data on Ropeginterferon Alfa-2b to Be Featured at EHA2022
Presentations to illustrate long-term results from the PROUD/CONTINUATION studies as well as new insights on ropeginterferon alfa-2b in polycythemia vera (PV) patients in Japan PharmaEssentia Corporation
Source: finanznachrichten.de